Roblox Valuation
Is RBLX * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of RBLX * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: RBLX * (MX$535) is trading below our estimate of fair value (MX$569.29)
Significantly Below Fair Value: RBLX * is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for RBLX *?
Other financial metrics that can be useful for relative valuation.
| What is RBLX *'s n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$21.13b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 7x |
| Enterprise Value/EBITDA | -19.5x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does RBLX *'s PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 4.3x | ||
TTWO Take-Two Interactive Software | 4.6x | 11.9% | US$25.3b |
SE Sea | 3x | 11.5% | US$39.4b |
EA Electronic Arts | 4.6x | 4.1% | US$34.1b |
3659 NEXON | 5.2x | 5.6% | JP¥2.2t |
RBLX * Roblox | 7.1x | 17.0% | Mex$21.1b |
Price-To-Sales vs Peers: RBLX * is expensive based on its Price-To-Sales Ratio (7.1x) compared to the peer average (4.3x).
Price to Earnings Ratio vs Industry
How does RBLX *'s PE Ratio compare vs other companies in the Global Entertainment Industry?
Price-To-Sales vs Industry: RBLX * is expensive based on its Price-To-Sales Ratio (7.1x) compared to the Global Entertainment industry average (2x).
Price to Sales Ratio vs Fair Ratio
What is RBLX *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 7.1x |
| Fair PS Ratio | 1.4x |
Price-To-Sales vs Fair Ratio: RBLX * is expensive based on its Price-To-Sales Ratio (7.1x) compared to the estimated Fair Price-To-Sales Ratio (1.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | Mex$535.00 | Mex$711.87 +33.1% | 18.8% | Mex$1,001.21 | Mex$417.17 | n/a | 28 |
| May ’25 | Mex$620.00 | Mex$853.74 +37.7% | 16.5% | Mex$1,102.65 | Mex$491.95 | n/a | 29 |
| Apr ’25 | Mex$629.00 | Mex$845.08 +34.4% | 16.6% | Mex$1,094.16 | Mex$488.16 | n/a | 29 |
| Mar ’25 | Mex$690.00 | Mex$848.56 +23.0% | 17.1% | Mex$1,108.38 | Mex$494.51 | n/a | 30 |
| Feb ’25 | Mex$706.00 | Mex$775.90 +9.9% | 20.2% | Mex$1,029.05 | Mex$445.92 | n/a | 30 |
| Jan ’25 | Mex$790.00 | Mex$756.69 -4.2% | 22.5% | Mex$1,030.07 | Mex$394.86 | n/a | 29 |
| Dec ’24 | Mex$689.00 | Mex$750.70 +9.0% | 22.9% | Mex$1,033.49 | Mex$396.17 | n/a | 28 |
| Nov ’24 | Mex$570.00 | Mex$709.32 +24.4% | 25.0% | Mex$1,086.39 | Mex$416.45 | n/a | 30 |
| Oct ’24 | Mex$488.00 | Mex$672.20 +37.7% | 25.6% | Mex$1,027.57 | Mex$393.90 | n/a | 29 |
| Sep ’24 | Mex$488.00 | Mex$675.89 +38.5% | 26.0% | Mex$1,023.08 | Mex$375.13 | n/a | 27 |
| Aug ’24 | Mex$656.00 | Mex$736.10 +12.2% | 26.0% | Mex$1,087.98 | Mex$368.24 | n/a | 27 |
| Jul ’24 | Mex$704.00 | Mex$751.03 +6.7% | 26.1% | Mex$1,112.85 | Mex$376.66 | n/a | 27 |
| Jun ’24 | Mex$750.00 | Mex$773.18 +3.1% | 27.2% | Mex$1,153.80 | Mex$337.26 | n/a | 26 |
| May ’24 | Mex$636.00 | Mex$807.32 +26.9% | 28.7% | Mex$1,172.09 | Mex$342.61 | Mex$620.00 | 24 |
| Apr ’24 | n/a | Mex$801.62 0% | 29.0% | Mex$1,171.46 | Mex$342.43 | Mex$629.00 | 24 |
| Mar ’24 | Mex$660.00 | Mex$776.61 +17.7% | 31.9% | Mex$1,176.69 | Mex$253.44 | Mex$690.00 | 25 |
| Feb ’24 | Mex$666.00 | Mex$708.31 +6.4% | 37.8% | Mex$1,322.09 | Mex$260.69 | Mex$706.00 | 26 |
| Jan ’24 | Mex$526.00 | Mex$768.12 +46.0% | 34.5% | Mex$1,382.07 | Mex$389.32 | Mex$790.00 | 25 |
| Dec ’23 | Mex$575.00 | Mex$806.94 +40.3% | 31.7% | Mex$1,371.20 | Mex$386.25 | Mex$689.00 | 23 |
| Nov ’23 | Mex$880.00 | Mex$930.38 +5.7% | 30.4% | Mex$1,495.72 | Mex$398.86 | Mex$570.00 | 23 |
| Oct ’23 | Mex$726.73 | Mex$952.86 +31.1% | 29.7% | Mex$1,502.93 | Mex$420.82 | Mex$488.00 | 20 |
| Sep ’23 | Mex$799.00 | Mex$981.59 +22.9% | 28.3% | Mex$1,508.91 | Mex$422.49 | Mex$488.00 | 19 |
| Aug ’23 | Mex$920.00 | Mex$855.70 -7.0% | 36.0% | Mex$1,629.91 | Mex$427.85 | Mex$656.00 | 19 |
| Jul ’23 | Mex$702.00 | Mex$841.63 +19.9% | 38.1% | Mex$1,627.58 | Mex$427.24 | Mex$704.00 | 19 |
| Jun ’23 | Mex$614.00 | Mex$845.92 +37.8% | 36.3% | Mex$1,568.06 | Mex$411.61 | Mex$750.00 | 19 |
| May ’23 | Mex$649.00 | Mex$1,328.77 +104.7% | 26.9% | Mex$2,039.03 | Mex$652.49 | Mex$636.00 | 18 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.